Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Biontech SE
Recent news which mentions Biontech SE
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Covid was declared a pandemic two years ago and now we're finally moving on — but public health experts say it's not over
March 11, 2022
Tags
BioNTech SE
Biotech and Pharmaceuticals
World economy
From
CNBC.com News
What's next for Pfizer, Moderna beyond their projected $51 billion in combined Covid vaccine sales this year
March 03, 2022
Tags
Politics
Epidemics
Pfizer Inc
From
CNBC.com News
UK to roll out additional Covid vaccine shot for over 75s and vulnerable people within weeks
February 21, 2022
Tags
World News
Coronavirus
Europe Politics
From
CNBC.com News
Indonesia relies heavily on China's Sinovac vaccine. A new wave of infections puts it to the test
February 21, 2022
Tags
Health care industry
Moderna Inc
Pharmaceuticals
From
CNBC.com News
Moderna, Pfizer stocks fall as omicron Covid wave subsides in U.S.
February 14, 2022
Tags
Business News
Policy
US Top News and Analysis
From
CNBC.com News
Pfizer director Dr. Scott Gottlieb: Shots for kids under 5 delayed due to low Covid cases in trial
February 14, 2022
Tags
Coronavirus
Biotech and Pharmaceuticals
Royal Caribbean Cruises Ltd
From
CNBC.com News
FDA plan to fast-track Pfizer vaccine for kids under 5 fails to deliver, leaving parents waiting until April
February 12, 2022
Tags
Business
Politics
Epidemics
From
CNBC.com News
Pfizer delays its FDA application to expand its Covid vaccine to kids under 5 until April
February 11, 2022
Tags
Markets
BioNTech SE
Biotech and Pharmaceuticals
From
CNBC.com News
No one knows when the pandemic will end after omicron upended most hope of returning to normal
February 11, 2022
Tags
U/S/ Economy
Merck & Co Inc
Breaking News: Business
From
CNBC.com News
Here's what experts say about Covid vaccines for kids under age 5: 'My infant ... will certainly be vaccinated'
February 10, 2022
Tags
Health Tips and Wellness Advice
BioNTech SE
Pfizer Inc
From
CNBC.com News
The CDC still needs to approve young kids' Covid shots, but it's telling health agencies to expect delivery by Feb. 21
February 09, 2022
Tags
Coronavirus
US Economy
US: News
From
CNBC.com News
Pfizer CEO says chances are 'very high' FDA will approve low-dose Covid shots for kids under 5
February 08, 2022
Tags
Biotech and Pharmaceuticals
Breaking News: Business
BioNTech SE
From
CNBC.com News
Pfizer expects $54 billion in 2022 sales on Covid vaccine and treatment pill
February 08, 2022
Tags
Health & Science
US Economy
Coronavirus
From
CNBC.com News
Pfizer starts submitting data for FDA emergency approval of vaccine for kids under 5
February 01, 2022
Tags
Disease outbreaks
Business
Pfizer Inc
From
CNBC.com News
What to watch today: Wall Street looks to start new month steady after terrible January
February 01, 2022
Tags
Exxon Mobil Corp
AT&T Inc
Cirrus Logic Inc
From
CNBC.com News
5 things to know before the stock market opens Tuesday
February 01, 2022
Tags
BioNTech SE
Interest Rates
General Motors Co
From
CNBC.com News
Stocks making the biggest moves in the premarket: AT&T, AMC Entertainment, UPS and more
February 01, 2022
Tags
Cirrus Logic Inc
U/S/ Markets
FedEx Corp
From
CNBC.com News
The next Covid variant will be more contagious than omicron, but the question is whether it will be more deadly, WHO says
January 25, 2022
Tags
Breaking News: Business
Biotech and Pharmaceuticals
BioNTech SE
From
CNBC.com News
What to watch today: Wall Street looks lower with Nasdaq pacing for 2% decline
January 25, 2022
Tags
General Electric Co
Polaris Inc
Microsoft Corp
From
CNBC.com News
5 things to know before the stock market opens Tuesday
January 25, 2022
Tags
Johnson & Johnson
Microsoft Corp
Apple Inc
From
CNBC.com News
Pfizer and BioNTech launch clinical study of Covid vaccine targeting omicron
January 25, 2022
Tags
Biotechnology
World News
US: News
From
CNBC.com News
Children under 5 are not eligible for Covid vaccination. Doctors have this advice to protect them during the omicron surge
January 21, 2022
Tags
Vaccinations
Disease outbreaks
Business
From
CNBC.com News
Kids' Covid hospitalizations hit pandemic high, worrying doctors and parents about long-term impact
January 21, 2022
Tags
Disease outbreaks
Vaccinations
Pfizer Inc
From
CNBC.com News
Singapore will extend Covid booster program to teens aged 12 to 17
January 21, 2022
Tags
COVID/19
Health care industry
Social issues
From
CNBC.com News
Arguing with your partner over Covid? You're not alone, with the pandemic straining many relationships
January 21, 2022
Tags
Coronavirus
Court decisions
Health & Science
From
CNBC.com News
What to watch today: Stocks set to open higher after Nasdaq entered correction territory
January 20, 2022
Tags
Netflix Inc
United Airlines Holdings Inc
American Airlines Group Inc
From
CNBC.com News
5 things to know before the stock market opens Thursday
January 20, 2022
Tags
Business
Pfizer Inc
Investment strategy
From
CNBC.com News
Fauci says FDA could authorize Pfizer's Covid vaccine for kids under 5 in the next month
January 19, 2022
Tags
BioNTech SE
Biotech and Pharmaceuticals
Breaking News: Business
From
CNBC.com News
'Obscene inequality': Oxfam says taxing the world's richest could help save lives
January 17, 2022
Tags
BioNTech SE
Taxes
Wealth
From
CNBC.com News
FDA shortens Moderna booster waiting period to 5 months for adults
January 07, 2022
Tags
US Top News and Analysis
Moderna Inc
Pandemics
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.